Chapter 1. SURGICAL SUTURES MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. SURGICAL SUTURES MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights  

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. SURGICAL SUTURES MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. SURGICAL SUTURES MARK ET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. SURGICAL SUTURES MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. SURGICAL SUTURES MARKET – By Product Type

6.1 Absorbable

6.2. Non-absorbable

Chapter 7. SURGICAL SUTURES MARKET – By Form

7.1 Natural

7.2. Synthetic

Chapter 8. SURGICAL SUTURES MARKET – By Application

8.1 Cardiology

8.2. General Surgery

8.3. Gynecology

8.4. Orthopedics

8.5. Others

Chapter 9. SURGICAL SUTURES MARKET –By End-Use

9.1 Hospitals and ASCs

9.2. Specialty Clinics

Chapter 10. SURGICAL SUTURES MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. SURGICAL SUTURES MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company  10